NJCCR: Pilot Program Research Grant

The NJCCR: Pilot Program Research Grant, offered by the New Jersey Department of Health, aims to tackle priority areas related to the causes of cancer. This two-year grant focuses on research into genetic, biochemical, and environmental factors, as well as behavioral and socioeconomic aspects. It encourages innovative approaches to pain management and cancer health disparities, fostering collaboration among stakeholders to improve outcomes for high-burden communities in New Jersey.

NOTE: All grant applicants that plan to submit a LOI (December 19, 2025) are required to attend the Virtual Technical Assistance (TA) session to be held on December 9, 2025, from 9:00 AM – to 11:00 AM. This session will provide an opportunity for applicants to review, clarify and ask questions about the RFA and the System for Administering Grants Electronically (SAGE).
New Jersey Department of Health (NJDOH)
The New Jersey Department of Health leads the state’s response to public health challenges and works to improve health outcomes for all New Jersey residents. Through its three primary branches—Public Health Services, Health Systems, and Integrated Health—the Department collaborates across programs and partners to strengthen New Jersey’s health system. Guided by its mission to protect public health, promote healthy communities, and improve the quality of health care, the Department supports initiatives that advance prevention, system integration, and equitable access to health services statewide.
The pilot is a 2 year grant designed to address current priority areas which focuses on the genetic, biochemical, viral, microgiological and environmental causes of cancer, and may include, but is not limited to: behavioral, socioeconomic, demographic and psycho social research or research into methods of clinical treatment (no clinical trials) or which focuses on pain management/palliative, cancer health disparities, immunotherapy/biologics for cancer, artificial intelligence and return on investment of cancer research grant.